Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Apr 20, 2009

Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments

Apr 16, 2009

Mylan Declares Quarterly Preferred Stock Dividend

Apr 14, 2009

Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment

Apr 13, 2009

Andrew G. Cuneo Joins Mylan as Vice President of Global Business Development

Apr 08, 2009

Mylan Announces Clarinex(R) Settlement Agreement

Mar 30, 2009

Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)

Mar 26, 2009

Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges

Mar 26, 2009

Mylan Confirms Four First-to-File Challenges

Mar 12, 2009

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

Feb 25, 2009

Mylan's Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor

Pagination

First page
Previous page
…
Page 86
Page 87
Page 88
Page 89
Current page 90
Page 91
Page 92
Page 93
Page 94
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.